Menu Search
Equities

Elekta AB (publ)

EKTA B:STO

Elekta AB (publ)

Actions
Health CareMedical Equipment and Services
  • Price (SEK)62.15
  • Today's Change0.35 / 0.57%
  • Shares traded77.11k
  • 1 Year change-30.26%
  • Beta1.1238
Data delayed at least 15 minutes, as of Nov 22 2024 10:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform3
Hold5
Sell6
Strong Sell2

Share price forecast in SEK

The 14 analysts offering 12 month price targets for Elekta AB (publ) have a median target of 70.50, with a high estimate of 110.00 and a low estimate of 57.00. The median estimate represents a 14.08% increase from the last price of 61.80.
High78.0%110.00
Med14.1%70.50
Low-7.8%57.00

Dividends in SEK

In 2024, Elekta AB (publ) reported a dividend of 2.40 SEK, equaling last years dividend. The 12 analysts covering the company expect dividends of 2.53 SEK for the upcoming fiscal year, an increase of 5.29%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in SEK

On Aug 28, 2024, Elekta AB (publ) reported 1st quarter 2025 earnings of 0.41 per share. This result exceeded the 0.34 consensus of the 2 analysts covering the company and under-performed last year's 1st quarter results by 36.92%.
The next earnings announcement is expected on Nov 27, 2024.
Average growth rate+2.28%
Elekta AB (publ) reported annual 2024 earnings of 3.62 per share on Jun 05, 2024.
Average growth rate+6.75%
More ▼

Revenue history & estimates in SEK

Elekta AB (publ) had 1st quarter 2025 revenues of 3.83bn. This bettered the 3.63bn consensus of the 3 analysts covering the company. This was 0.08% below the prior year's 1st quarter results.
Average growth rate+1.59%
Elekta AB (publ) had revenues for the full year 2024 of 18.12bn. This was 7.41% above the prior year's results.
Average growth rate+5.83%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.